Sanofi refocuses its French manufacturing capacity
April 1, 2010Manufacturing and Production Dengue fever, Sanofi Pasteur, biologics
Sanofi-Aventis has set aside a 150 million euro ($200m) war chest to fund a major expansion of its biologic manufacturing …
Chiltern Announces Investment in Endpoint
April 1, 2010Research and Development
Glenn Kerkhof, Chiltern CEO, stated, “Chiltern’s decision to invest in Endpoint is representative of our commitment to seek collaborations which …
PAN makes board promotions
April 1, 2010Medical Communications Creston, Pan, appointment, medical communications
PAN Advertising has promoted Ben Davies (pictured right) to chief executive as part of a trio of promotions within its …
Healthcare reform momentus for pharma too
April 1, 2010Obama, US, biosimilars, healthcare reform
Historic reforms of America’s healthcare system have now passed into law, representing its most radical overhaul ever. Nevertheless, the bill …
GSK signs RNA therapeutics alliance
March 31, 2010Research and Development GlaxoSmithKline, Isis, RNA
GlaxoSmithKline has forged a new strategic alliance with Isis Pharmaceuticals to exploit the specialist company’s expertise in anti-RNA therapeutics. California-based …
Generic substitution will not deliver significant NHS savings, says EMIG
March 31, 2010Sales and Marketing EMIG, NHS, generics
The Department of Health’s plans for automatic generic substitution will not result in significant savings for the NHS and should …
Boehringer enters the venture capital business
March 31, 2010Research and Development, Sales and Marketing Boehringer, funding, venture capital
Boehringer Ingelheim is to tap into commercial opportunities in emerging technology by launching its own venture capital business. The Boehringer …
EMA calls for generic clopidogrel recall
March 31, 2010Manufacturing and Production Plavix, clopidogrel
Problems at a manufacturing facility in India have resulted in eight generic version of the antiplatelet agent clopidogrel being recalled …
Lilly expands trial supply deal with Thermo
March 31, 2010Manufacturing and Production, Research and Development Thermo Fisher Scientifitic, lilly
Eli Lilly has expanded a clinical trial materials supply agreement with Thermo Fisher Scientific in yet another deal that sees …
Digital Pharma: Byte-sized roundup
March 30, 2010Medical Communications digital pharma
This week’s roundup of digital developments includes GSK in the new UK web archive, WebMD launches social networking site, Boehringer …
German price cuts denounced by industry
March 30, 2010Sales and Marketing Germany, IQWIG
Pharma industry organisations have reacted angrily to new government plans in Germany which would enforce mandatory price reductions one year …
NICE changes its mind on Multaq
March 30, 2010Sales and Marketing Multaq, NICE, Sanofi-Aventis
NICE has given preliminary approval of Sanofi-Aventis’ Multaq for the management of patients with atrial fibrillation. The decision reverses an …
Russia debates pharma reform
March 30, 2010Sales and Marketing Russia, em, emerging markets
The US is not the only country in the throes of passing significant legislation on major health issues.A bill has …
Cordis appoints Christian Spaulding
March 30, 2010Cordis, Johnson & Johnson, appointment, research and development
Johnson & Johnson’s vascular technology company Cordis has appointed Dr Christian Spaulding worldwide VP of medical affairs. He assumes the …
Contract research news in brief
March 30, 2010Research and Development CRO, Kendle
This week’s round-up of news in the contract research arena includes a fundraising for Irish CRO Venn Life Sciences, ISO …
Antisoma cancer drug fails in phase III
March 29, 2010Research and Development Antisoma, NSCLC, lung cancer
UK biotech Antisoma has suffered a disappointing late-stage failure with a potential lung cancer treatment it was developing with Novartis. …
FDA flexes muscles over ailing Genzyme plant
March 29, 2010Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance
Manufacturing compliance problems continue to weigh down US biotechnology company Genzyme, with the US Food and Drug Administration now saying …
Funding boost for UK research
March 29, 2010Research and Development Cancer Research UK, MRC, UCL, UKCMRI, Wellcome
Prime minister Gordon Brown has pledged £250 million for the planned UK Centre for Medical Research and Innovation (UKCMRI). The …
Lights go out for Earth Hour
March 29, 2010Sales and Marketing charity, disaster
Over the weekend lights went out at heritage sites, modern marvels and royal palaces in honour of the World Wildlife …
CMG launches digital division
March 29, 2010Medical Communications Complete Digital, Complete Medical Group, digi, digi pharma, digital pharma
Healthcare communications agency Complete Medical Group (CMG) has launched an online division to take advantage of a shift in the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
